ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Impact of Serum EDTA Treatment on Identification of Unacceptable Antigens for Kidney Transplant Candidates.

J. Xin, N. Brown, R. Upchurch, J. Weidner, S. Marino.

Pathology, University of Chicago Medicine, Chicago, IL

Meeting: 2017 American Transplant Congress

Abstract number: C24

Keywords: Highly-sensitized, HLA antibodies, Kidney transplantation, Waiting lists

Session Information

Session Name: Poster Session C: Deceased Donor Issues II: DCD, DGF, AKI, En-Bloc

Session Type: Poster Session

Date: Monday, May 1, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

BACKGROUND AND AIMS: The prozone effect is one factor causing false negative reactions in HLA antibody testing. EDTA, which is commonly used to remove this effect, may result in the identification of HLA antibodies that were previously masked by prozone. These unmasked antibodies may in turn, increase the number of unacceptable antigens entered into UNOS. The current study aimed to determine whether the unacceptable antigens submitted to UNOS changed after the implementation of EDTA serum-treatment. Furthermore, we investigated cPRA changes, in particular, those leading to cPRA >98%.

PATIENTS AND METHODS: We retrospectively reviewed the reports that our laboratory submitted to UNOS on behalf of renal transplant candidates whose monthly samples were tested in our laboratory pre- and post-implementation of EDTA serum-treatment. A total of 199 patients were included in this study. The reports pre- and post-implementation of EDTA treatment were reviewed and compared for cPRA and unacceptable antigens reported to UNOS.

RESULTS: cPRA increase after EDTA treatment was observed in 45 of 199 patients (22.6%). By reviewing the dilution results for these patients, we identified 19 patients (42.2 %) with prozone effect. The distribution of prozone effect included 64.4% class I antibody, 16% class II, and 20% in both class I and class II. Importantly, among these 45 patients with cPRA increases, 8 of them (17.8%) had a cPRA greater than 98% after EDTA treatment.

CONCLUSION: The analysis of single antigen beads' MFI revealed that EDTA treatment removed the prozone effect in all tested samples and unmasked strong antibodies. Accordingly, the number of unacceptable antigens and cPRA were increased in patients with prozone effect. The removal of prozone effect by EDTA treatment led to an increase in patients with cPRA greater than 98%, which has a direct impact on patient's priority on the waiting list.

CITATION INFORMATION: Xin J, Brown N, Upchurch R, Weidner J, Marino S. Impact of Serum EDTA Treatment on Identification of Unacceptable Antigens for Kidney Transplant Candidates. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Xin J, Brown N, Upchurch R, Weidner J, Marino S. Impact of Serum EDTA Treatment on Identification of Unacceptable Antigens for Kidney Transplant Candidates. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-serum-edta-treatment-on-identification-of-unacceptable-antigens-for-kidney-transplant-candidates/. Accessed May 9, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences